Carlo G. Tocchetti

31.3k total citations · 3 hit papers
153 papers, 7.6k citations indexed

About

Carlo G. Tocchetti is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Carlo G. Tocchetti has authored 153 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Cardiology and Cardiovascular Medicine, 37 papers in Physiology and 33 papers in Molecular Biology. Recurrent topics in Carlo G. Tocchetti's work include Chemotherapy-induced cardiotoxicity and mitigation (45 papers), Cardiovascular Function and Risk Factors (37 papers) and Heart Failure Treatment and Management (29 papers). Carlo G. Tocchetti is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (45 papers), Cardiovascular Function and Risk Factors (37 papers) and Heart Failure Treatment and Management (29 papers). Carlo G. Tocchetti collaborates with scholars based in Italy, United States and Netherlands. Carlo G. Tocchetti's co-authors include An L. Moens, Kathleen L. Gabrielson, Yanti Octavia, Harry J.G.M. Crijns, Stefan Janssens, Nazareno Paolocci, David A. Kass, Gilda Varricchi, Valentina Mercurio and David A. Wink and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Circulation.

In The Last Decade

Carlo G. Tocchetti

151 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

2012 1.1k citations Carlo G. Tocchetti et al. profile →
Cardiovascular toxicities associated with immune checkpoint inhibitors

2019 342 citations Carlo G. Tocchetti, Alexander R. Lyon et al. profile →
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging

2024 82 citations Carlo G. Tocchetti et al. profile →

Peers

Countries citing papers authored by Carlo G. Tocchetti

Since Specialization

Citations

This map shows the geographic impact of Carlo G. Tocchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo G. Tocchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo G. Tocchetti more than expected).

Fields of papers citing papers by Carlo G. Tocchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo G. Tocchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo G. Tocchetti. The network helps show where Carlo G. Tocchetti may publish in the future.

Co-authorship network of co-authors of Carlo G. Tocchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo G. Tocchetti. A scholar is included among the top collaborators of Carlo G. Tocchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo G. Tocchetti. Carlo G. Tocchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis 2025 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), Martino Deidda, (unknown), Vincenzo Quagliariello, Nicola Maurea, Carlo G. Tocchetti, Pietro Ameri, (unknown)	0
2	Prevention of Peripherally Inserted Central Catheter (PICC)-Associated Vein Thrombosis in Cancer: A Narrative Review 2025 ·Biomedicines ·(unknown), Pietro Scicchitano, Daniele La Forgia, Raffaele De Luca, (unknown), Carlo G. Tocchetti, Marcello Di Nisio, Stefano Oliva	3
3	Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target 2025 ·International Journal of Molecular Sciences ·Michele Correale, Valentina Mercurio, (unknown), Beatrice Pezzuto, Lucia Tricarico, (unknown), Angela Raucci, Anne Lise Ferrara, Stefania Loffredo, (unknown), Massimo Iacoviello, Maurizio Margaglione, (unknown), Carlo G. Tocchetti, (unknown), Claudio Mussolino, Maria Cristina Vinci	1
4	Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 2025 ·International Journal of Molecular Sciences ·Anna Grimaldi, Roberta D’Assante, (unknown), Simone Marcella, Stefania Paolillo, Francesco Cacciatore, Valentina Mercurio, Eduardo Bossone, Antonio Cittadini, Carlo G. Tocchetti, Mariarosaria Incoronato	1
5	Inflammation in cardio-oncology: beyond immunotherapies 2024 ·European Heart Journal ·Anne Lise Ferrara, Stefania Loffredo, Carlo G. Tocchetti	1
6	Inferior Vena Cava Filter in Cancer-Associated Thrombosis: A Vade Mecum for the Treating Physicians: A Narrative Review 2024 ·Biomedicines ·(unknown), Daniele La Forgia, Pietro Scicchitano, Natale Daniele Brunetti, Riccardo Inchingolo, Carlo G. Tocchetti, Stefano Oliva	2
7	The broad spectrum of cardiotoxicities from immunotherapies 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), Alessandra Cuomo, Giancarlo Marone, Remo Poto, Gilda Varricchi, Leonardo Cristinziano, Maria Rosaria Galdiero, Anne Lise Ferrara, Stefania Loffredo, Luigi Formisano, Teresa Troiani, Valentina Mercurio, Carlo G. Tocchetti	2
8	Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19 2022 ·Journal of the American College of Cardiology ·Stéphane Heymans, Dana Dawson, Valentı́n Fuster, Marco Metra, Carlo G. Tocchetti	3
9	HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation 2022 ·Antioxidants ·Daniele Mancardi, Pasquale Pagliaro, Lisa A. Ridnour, Carlo G. Tocchetti, Katrina M. Miranda, Magdalena Juhaszova, Steven J. Sollott, David A. Wink, Nazareno Paolocci	18
10	Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes 2020 ·Scientific Reports ·Gianluca Testa, Michele Russo, (unknown), (unknown), Silvia Parisi, Flora Pirozzi, Carlo G. Tocchetti, Pasquale Abete, Domenico Bonaduce, Tommaso Russo, Fabiana Passaro	31
11	Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC) 2020 ·Antioxidants ·Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, Martino Deidda, Daniela Di Lisi, Giuseppina Novo, Roberta Manganaro, Concetta Zito, Ciro Santoro, Pietro Ameri, Paolo Spallarossa, Eleonora Arboscello, Carlo G. Tocchetti, Cláudia Penna	22
12	Sex‐related differences in COVID‐19 lethality 2020 ·British Journal of Pharmacology ·Cláudia Penna, Valentina Mercurio, Carlo G. Tocchetti, Pasquale Pagliaro	63
13	Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 2019 ·Heart Failure Reviews ·Christian Cadeddu Dessalvi, Alessia Pepe, Cláudia Penna, Alessia Gimelli, Rosalinda Madonna, Donato Mele, Ines Monte, Giuseppina Novo, Cinzia Nugara, Concetta Zito, Javid J. Moslehi, Rudolf A. de Boer, Alexander R. Lyon, Carlo G. Tocchetti, Giuseppe Mercuro	35
14	Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients 2019 ·International Journal of Molecular Sciences ·Valentina Mercurio, (unknown), Letizia Barbieri, Paolo Parrella, (unknown), B Liccardo, Domenico Bonaduce, Carlo G. Tocchetti, Amato de Paulis, Francesca Wanda Rossi	30
15	Metabolic remodelling of glucose, fatty acid and redox pathways in the heart of type 2 diabetic mice 2018 ·The Journal of Physiology ·Sonia Cortassa, Viviane Caceres, Carlo G. Tocchetti, Michel Bernier, Rafael de Cabo, Nazareno Paolocci, Steven J. Sollott, Miguel A. Aon	30
16	Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed 2017 ·Stem Cells International ·Fabiana Passaro, Gianluca Testa, (unknown), Ciro Costagliola, Carlo G. Tocchetti, (unknown), Michele Russo, Flora Pirozzi, Pasquale Abete, Tommaso Russo, Domenico Bonaduce	18
17	Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction 2014 ·European Journal of Heart Failure ·Carlo G. Tocchetti, Andrea Carpi, Carmela Coppola, Cristina Quintavalle, Domenica Rea, (unknown), Antonella Arcari, Giovanna Piscopo, (unknown), M. Monti, Claudia De Lorenzo, Claudio Arra, Gerolama Condorelli, Fabio Di Lisa, Nicola Maurea	78
18	ESC Working Group on Myocardial Function Position Paper: How to Study the Right Ventricle in Experimental Models 2014 ·European Journal of Heart Failure ·Adelino Leite‐Moreira, André P. Lourenço, Jean‐Luc Balligand, Johann Bauersachs, Angela Clerk, León J. De Windt, Stéphane Heymans, Denise Hilfiker‐Kleiner, Emilio Hirsch, Guido Iaccarino, Karol Kamiński, Ralph Knöll, Manuel Mayr, Guido Tarone, Thomas Thum, Carlo G. Tocchetti	10
19	The Emerging Issue of Cardiac Dysfunction Induced by Antineoplastic Angiogenesis Inhibitors 2013 ·European Journal of Heart Failure ·Carlo G. Tocchetti, Giuseppina Gallucci, Carmela Coppola, Giovanna Piscopo, (unknown), (unknown), Aldo Giudice, Rosario V. Iaffaioli, Claudio Arra, Nicola Maurea	59
20	Detection, Monitoring, and Management of Trastuzumab-Induced Left Ventricular Dysfunction: An Actual Challenge 2012 ·European Journal of Heart Failure ·Carlo G. Tocchetti, Gianluca Ragone, Carmela Coppola, Domenica Rea, Giovanna Piscopo, Stefania Scala, Claudia De Lorenzo, Rosario V. Iaffaioli, Claudio Arra, Nicola Maurea	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact